Search Protocols under revision. Back New search Go to resultsDiseaseMain groupCross-Sectional, Transplantation, Cellular TherapyProtocol groupTransplantationDiseaseAcute Promyelocytic LeukemiaEwing SarcomaStem Cell Transplantation, AutologousSubgroupICD10C40.-C41.-C92.4-Z94.80MeSHSarcoma, EwingTransplantation, AutologousSequenceChemotherapyChemo-substanceChemo-substanceChemo-substanceChemo-substanceNo. Substances RadiotherapySupportive therapySupportive substanceBalanced Crystalloid SolutionBusulfanCiprofloxacinCotrimoxazoleDexamethasoneFosaprepitantGranisetronLevetiracetamMelphalanUrsodeoxycholic acidValaciclovirSupportive substanceBalanced Crystalloid SolutionBusulfanCiprofloxacinCotrimoxazoleDexamethasoneFosaprepitantGranisetronLevetiracetamMelphalanUrsodeoxycholic acidValaciclovirSupportive substanceBalanced Crystalloid SolutionBusulfanCiprofloxacinCotrimoxazoleDexamethasoneFosaprepitantGranisetronLevetiracetamMelphalanUrsodeoxycholic acidValaciclovirSupportive substanceBalanced Crystalloid SolutionBusulfanCiprofloxacinCotrimoxazoleDexamethasoneFosaprepitantGranisetronLevetiracetamMelphalanUrsodeoxycholic acidValaciclovirNo. Substances11Protocol classificationTherapy classificationcurrent standardIntensityHochdosis, bei autologer SZTTherapy indicationFirst lineTherapy phaseautologous stem cell transplantationTherapy intentioncurativeRisksAnemia Hb below 8g/dlDiarrheaEmetogenicity (MASCC/ESMO)Febrile NeutropeniaGastrointestinal ToxicityIncrease AminotransferasesInfectionsMyositisNeutropeniaPyrexiaRashThrombocytopenia below 50 000/µl only studiesPublicationAuthorMata Fernandez CDiseaseEwing-SarkomOriginEuro-E.W.I.N.G.99 and Ewing-2008Protokolle in Überarbeitung 1 protocol foundBusulfan 3.2 / Melphalan 140, Autologous Stem Cell Transplantation (PID76 V1.1)
